CUSIP: 92189F387
Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / SHRT HGH YLD MUN
-
Total 13F shares
-
6,418,663
-
Share change
-
+1,145,052
-
Total reported value
-
$162,311,214
-
Price per share
-
$25.45
-
Number of holders
-
93
-
Value change
-
+$28,751,483
-
Number of buys
-
65
-
Number of sells
-
15
Security key
92189F387
Report period
Q2 2021
Institutions
93
Top holders
10
Reporting periods
Holder history for CUSIP 92189F387
Recent filing periods:
Top shareholders of SHYD - VANECK ETF TRUST - SHRT HGH YLD MUN (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) as of Q2 2021
As of 30 Jun 2021,
VANECK ETF TRUST - SHRT HGH YLD MUN (SHYD) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,418,663 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, ENVESTNET ASSET MANAGEMENT INC, ROYAL BANK OF CANADA, LPL Financial LLC, UBS Group AG, TRUIST FINANCIAL CORP, AMERIPRISE FINANCIAL INC, and Tortoise Investment Management, LLC.
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2021 vs Q1 2021 Across Filers
| Investor |
Q1 2021 Shares |
Q2 2021 Shares |
Share Diff |
Share Chg % |
Q1 2021 Value $ |
Q2 2021 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.